| Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 20712525 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: Genetic variability within the SLCO1B1 and ABCB1 transporter genes has been associated with modification of statin effectiveness in cholesterol management. MATERIALS & METHODS: We conducted a case-control study using a population-based registry of pharmacy records linked to the hospital discharge records. Within a hypercholesterolemic cohort, we included 668 myocardial infarction cases and 1217 controls. RESULTS: We tested 24 tagging SNPs and found two SNPs within ABCB1 (rs3789244, p = 0.01; rs1922242, p = 0.01) to interact with statin treatment. In addition, we found a nonsignificant haplotype-treatment interaction (p = 0.054). The odds ratio for subjects homozygous for SLCO1B1*1A was 0.49 (95% CI: 0.34-0.71) compared with 0.31 (95% CI: 0.24-0.41) for heterozygous or noncarriers of the *1A allele. CONCLUSION: This is the first study to demonstrate that common genetic variability within the SLCO1B1 and ABCB1 genes is associated with the modification of the effectiveness of statins in the prevention of the clinical outcome, myocardial infarction. |
| | |
Authors:
|
Bas J M Peters; Andrei S Rodin; Olaf H Klungel; Cornelia M van Duijn; Bruno H Ch Stricker; Ruben van't Slot; Anthonius de Boer; Anke-Hilse Maitland-van der Zee |
Related Documents
:
|
20398095 - Statins decrease adverse outcomes in coronary artery bypass for extensive coronary arte... 7514505 - Lp(a): an acute-phase reactant? 4060165 - Exaggerated nicotine-induced norepinephrine release from atherosclerotic rabbit hearts. 18473965 - Is atorvastatin superior to other statins? analysis of the clinical trials with atorvas... 21159165 - The effect of tobacco smoking and treatment strategy on the one-year mortality of patie... 8589875 - Elevated defibrillation threshold when right-sided venous access is used for nonthoraco... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pharmacogenomics Volume: 11 ISSN: 1744-8042 ISO Abbreviation: Pharmacogenomics Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-08-17 Completed Date: 2010-12-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897350 Medline TA: Pharmacogenomics Country: England |
Other Details:
|
Languages: eng Pagination: 1065-76 Citation Subset: IM |
Affiliation:
|
Faculty of Science, Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht University, Utrecht, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Case-Control Studies Female Haplotypes Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage, therapeutic use* Incidence Logistic Models Male Medical Records Middle Aged Myocardial Infarction / epidemiology, genetics, prevention & control* Organic Anion Transporters / genetics* P-Glycoprotein / genetics* Pharmacogenetics* Polymorphism, Single Nucleotide* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/ABCB1 protein, human; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Organic Anion Transporters; 0/P-Glycoprotein; 0/SLCO1B1 protein, human |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation...
Next Document: Interethnic comparisons of important pharmacology genes using SNP databases: potential application t...